Abstract:Objective: In an earlier study, we obtained androgen-independent prostate cancer cells (LNCaP-AI) and flutamide tolerant-LNCaP-AI (LNCaP-AI+F cells) that could survive in an androgen-free environment without or with flutamide, respectively. In the present study, we investigated the molecular mechanism of the castration resistance. Material and Methods: qRT-PCR was applied to measure the expression levels of genes coding for enzymes in the lysophosphatidylcholine (LPC) metabolic pathway and responsible for cholesterol and androgen metabolism in these cell lines. An ExProfile (TM) Human PI3K-AKT Signaling Related Gene qPCR Array was also used to investigate the expression levels of genes in the intracellular metabolic pathways in an emasculated hormone environment. Results: Compared with androgen-responsive prostate cancer (LNCaP) cells, phospholipase D1 (PLD1) expression was increased 259- and 410-folds in LNCaP-AI and LNCaP-AI+ F cells, respectively, and the PI3K/AKT signaling pathway was enhanced. Additionally, the expression of cholesterol metabolic enzymes and rate-limiting enzymes, such as organic anion-transporting polypeptide 1B3 (OATP1B3) (LNCaP-AI cells: 19.08-fold; LNCaP-AI+ F cells: 14.34-fold), low density lipoprotein receptor (LDL-r) (LNCaP-AI cells: 23.34-fold; LNCaP-AI+ F cells: 8.78-fold), squalene epoxidase (SQLE) (LNCaP-AI cells: 22.03-fold; LNCaP-AI+ F cells: 10.27-fold), and scavenger receptor B1 (SCARB1) (LNCaP-AI cells: 10.27-fold; LNCaP-AI+ F cells: 5.75-fold), was significantly increased. Furthermore, the expression of androgen synthetases, such as steroid 17-alpha-monooxygenase (CYP17A1) (LNCaP-AI cells: 28.59-fold; LNCaP-AI+ F cells: 4.32-fold), steroid 5 alpha-reductase 2 (SRD5A2) (LNCaP-AI cells: 51.50-fold; LNCaP-AI+ F cells: 12.91-fold), aldo-keto reductases (AKR1C1, AKR1C2, AKR1C3) (LNCaP-AI: 8.63-fold; LNCaP-AI+ F cells: 7.10-fold), and androgen receptor (AR) (LNCaP-AI: 39.18-fold; LNCaP-AI+ F cells: 36.56-fold), was increased significantly (P < 0.05). Conclusions: Our results revealed that the survival of LNCaP AI cells in androgen-free medium is due to self-synthesis of androgen, increased cholesterol intake and increased AR expression. These evidences suggest that the castration-resistant LNCaP cells are not androgen-independent but have developed or activated a set of AR-related signaling pathways to increase endogenous androgen biosynthesis and AR expression.

Autophagy protects LNCaP cells under androgen deprivation conditions.

Hypoxia-induced Autophagy Promotes Human Prostate Stromal Cells Survival and ER-stress

Inhibition of autophagy leads to increased apoptosis in LNCaP cells under androgen deprivation conditions

Targeting Androgen Receptor Leads to Suppression of Prostate Cancer Via Induction of Autophagy

Crosstalk Between Apoptosis and Autophagy in Prostate Epithelial Cells under Androgen Deprivation

Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model

Inhibition Of Androgen Induces Autophagy In Benign Prostate Epithelial Cells

Androgen-Independent Lncap Cells Are A Subline Of Lncap Cells With A More Aggressive Phenotype And Androgen Suppresses Their Growth By Inducing Cell Cycle Arrest At The G1 Phase

Inhibition of Autophagy Improves the Efficacy of Abiraterone for the Treatment of Prostate Cancer

TP53 Loss‐of‐function Causes Vulnerability to Autophagy Inhibition in Aggressive Prostate Cancer

Expression Profiling Of Genes In Androgen Metabolism In Androgen-Independent Prostate Cancer Cells Under An Androgen-Deprived Environment: Mechanisms Of Castration Resistance

Autophagy pathway is required for IL-6 induced neuroendocrine differentiation and chemoresistance of prostate cancer LNCaP cells

Downregulation of Lysine-Specific Demethylase 1 Enhances the Sensitivity of Hormone-Sensitive Prostate Cancer Cells to Androgen Deprivation Therapy.

Differential Phosphoprotein Levels and Pathway Analysis Identify the Transition Mechanism of LNCaP Cells into Androgen‐independent Cells

Elevated Levels of Autophagy-Related Marker ULK1 and Mitochondrion-Associated Autophagy Inhibitor LRPPRC Are Associated with Biochemical Progression and Overall Survival after Androgen Deprivation Therapy in Patients with Metastatic Prostate Cancer

Acute Hypoxia Induces Apoptosis in Serum-Deprived Prostate Cancer LNCaP Cells

Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.

Simultaneous Autophagy and Androgen Receptor Inhibition in a Prostate Cancer Xenograft Model

Upregulated KDM4B promotes prostate cancer cell proliferation by activating autophagy

Inhibition of autophagy promotes apoptosis and enhances anticancer efficacy of adriamycin via augmented ROS generation in prostate cancer cells

Ambra1 Induces Autophagy and Desensitizes Human Prostate Cancer Cells to Cisplatin.